Turn the recommendation into monthly income.

Your doctor recommends a supplement or eyelid-care product. Your practice chooses how to offer it: in the office (first month free, first bottle in hand, or EnrollPRO beside the chart) or at home (text, email, your branded store, or a script-pad slip). The patient enrolls and pays through secure checkout, products ship to their door on a repeat schedule, your practice is notified, and every qualifying repeat order earns your practice about $14 per patient per month.

Nothing. No setup fee, no monthly fee, no inventory, no shipping. Doc2Home is revenue share: patients pay for their products, you earn the commission on qualifying orders. Activate the same day. Commission is revenue, not net profit; keep your own costs in view.

It is the figure used in the Doc2Home presentation: about $14 of profit to your practice on each monthly order, which is the patient price minus the Lunovus wholesale price. Your number depends on the price you set and the products the patient takes, so treat it as an illustration and confirm it for your practice on the setup call.

Average retention is about 85% at 6 months and about 70% at 12 months. Patients on AREDS 2 formulas stay longer than patients on omega-3s because the AREDS 2 protocol is open-ended. The compounding is real: a practice that enrolls 5 patients a week reaches about $3,600 a month in commission within 12 months, before any cancellations.

No. They are designed to work together. Keep a small first-bottle stock or your regular in-office retail for patients who want to leave with product in hand, hand over the first bottle and have the refills delivered, or enroll the patient for home delivery from the start. Bulk Order supplies the shelf; Doc2Home handles the follow-through.

Most vision and medical plans do not cover over-the-counter supplements. Doc2Home is patient-pay; we do not bill insurance. In the rare HSA/FSA case, the patient can submit their Doc2Home receipt to their administrator.

EnrollPRO is the guided in-office step; Doc2Home is the platform behind it. On supported browser-based EHRs, EnrollPRO recognizes relevant chart information, suggests the products your practice selected, and pre-fills patient details for staff review, so enrollment becomes a step alongside the chart instead of a separate product hunt. It is a free enhancement for Doc2Home practices. Doc2Home also works without it: the text, email, branded-store and script-pad paths need no EHR integration.

Yes, on eligible subscriptions. It is the fastest way to get someone started while they are still in your office. Future charges and renewal terms are disclosed to the patient at enrollment, so there are no surprises in month two. Introductory offers delay paid revenue, which is why the income illustration counts active paying patients rather than enrollments.

Yes. Doc2Home emails your practice when a patient signs up for, or cancels, a supplement or eyelid-care plan. New patients can receive a welcome letter with your practice branding, and a patient who cancels can receive a practice-branded follow-up inviting questions. These show enrollment activity, not confirmed adherence; whether a patient took every dose stays a clinical conversation.

MultiCare gives participating practices a way to bring qualifying non-Lunovus products into the same Doc2Home enrollment, payment and delivery workflow, so a brand you already recommend does not have to live outside the system. Availability and commissions follow the program terms; ask us which products qualify.

Eye-care supplements (AREDS 2 formula macular support, omega-3 tear support, eye wellness multivitamins) alongside eyelid-care products such as Blephadex and Lid Revive. Manufactured in the USA in FDA-inspected, GMP-compliant facilities and third-party tested. Patients can be enrolled in one or several products, and MultiCare lets participating practices add qualifying non-Lunovus products under the program terms.